2060 Journal of Natural Products, 2009, Vol. 72, No. 11
Notes
were added to a solution of 10 (125 mg, 0.216 mmol) in dry THF (4
mL); then DIAD (51 µL, 0.26 mmol) was added at 0 °C. The mixture
was stirred at rt for 18 h; then the solvent was removed at reduced
pressure and the crude product purified by FCC (eluent petroleum ether/
Acknowledgment. We thank MiUR and Ente Cassa di Risparmio
di Firenze, Italy, for financial support. Ente CRF is also acknowledged
for granting a 400 MHz NMR spectrometer. Brunella Innocenti and
Maurizio Passaponti (Dipartimento di Chimica Organica “U. Schiff”)
are acknowledged for technical assistance. CINMPIS is gratefully
acknowledged for a grant to C.P.
EtOAc, 5:1, then 1:1): 111 mg, 0.162 mmol, 75%; [R]28 -55.6 (c
D
0.25, CH2Cl2); IR (CDCl3) cm-1 1726; 1H NMR (CDCl3) δ 8.00-7.98
(m, 2H), 7.52-7.48 (m, 1H), 7.37-7.33 (m, 2H), 7.28-7.13 (m, 20H,
Ar), 5.63 (d, J ) 5.4 Hz, H-6), 4.60 (d, J ) 11.2 Hz, 1H, Bn),
4.53-4.29 (m, 7H, Bn), 4.23-4.15 (m, 2H, H-2 + H-3), 4.01 (dd, J
) 6.8, 5.4 Hz, 1H, H-7a), 3.90 (dd, J ) 6.8, 5.4 Hz, 1H, H-7), 3.70
Note Added after ASAP Publication: The version of this paper
published on October 16, 2009, had refs 12 and 13 mislabeled. The
corrected version was published on October 21, 2009.
(dd, J ) 5.4, 3.4 Hz, 1H, H-1), 3.63-3.52 (m, 2H, Ha-8 + Hb-8); 13
C
Supporting Information Available: Comparison of 1H and 13C
NMR data for synthetic and isolated (-)-uniflorine A and synthetic
(+)-uniflorine A (Table 1). Synthetic procedures and characterization
for compounds 8, 9, and 10. Copies of 1H, 13C NMR and 1D NOESY
spectra for compounds 11 and 3 and 1H and 13C NMR spectra for
compounds 8, 9, 10, and 12. This material is available free of charge
NMR (CDCl3) δ 168.4 (s), 165.1 (s, C-5), 137.6-136.5 (s, 5C), 133.0
(d, 1C), 139.7-128.9 (d, 2C), 128.1-127.2 (d, 22C), 85.4 (d, 2C, C-1
+ C-2), 77.8 (d, C-7), 72.9-71.5 (t, Bn), 72.3 (d, C-6), 68.4 (d, C-7a),
67.9 (t, C-8), 59.2 (d, C-3); MS (ESI) m/z 706 (100, [M + Na]+);
anal. C, 75.16%; H, 6.37%; N, 1.95%, calcd for C43H41NO7, C, 75.53%;
H, 6.04%; N, 2.05%.
(1R,2R,3R,6S,7S,7aS)-1,2,7-Tri(benzyloxy)-3-[(benzyloxy)meth-
yl]hexahydro-1H-pyrrolizin-6-ol (12). LiAlH4 (25 mg, 0.66 mmol)
was added to a solution of 11 (111 mg, 0.162 mmol) in dry THF (3
mL). The mixture was stirred at reflux under nitrogen atmosphere for
5 h; then 0.30 mL of a saturated solution of Na2SO4 was added dropwise
at room temperature. The resulting mixture was filtered through Celite
and washed with EtOAc, and then the solvent was evaporated.
Purification of the crude product by FCC (eluent petroleum ether/
EtOAc, 1:1) gave pure 12 as a pale yellow oil (42 mg, 0.074 mmol,
References and Notes
(1) Matsumura, T.; Kasai, M.; Hayashi, T.; Arisawa, M.; Momose, Y.;
Arai, I.; Amagaya, S.; Komatsu, Y. Pharm. Biol. 2000, 38, 302–307.
(2) Davis, A. S.; Pyne, S. G.; Skelton, B. W.; White, A. H. J. Org. Chem.
2004, 69, 3139–3143.
(3) Karanjule, N. S.; Markad, S. D.; Dhavale, D. D. J. Org. Chem. 2006,
71, 6273–6276.
(4) 1-epi-1 and 1,2-di-epi-1: Zhao, Z.; Song, L.; Mariano, P. S. Tetrahe-
dron 2005, 61, 8888–8894.
(5) 1,2-Di-epi-1: Bell, A. W.; Pickering, L.; Watson, A. A.; Nash, R. J.;
Griffiths, R. C.; Jones, M. G.; Fleet, G. W. J. Tetrahedron Lett. 1996,
37, 8561–8564.
(6) 1,2-Di-epi-1 and 2-epi-1: Davis, A. S.; Ritthiwigrom, T.; Pyne, S. G.
Tetrahedron 2008, 64, 4868–4879.
(7) 8a-epi-1 and 1,2,8a-tri-epi-1: see ref 3.
(8) Asano, N.; Oseki, K.; Kaneko, E.; Matsui, K. Carbohydr. Res. 1994,
258, 255–266.
(9) Cardona, F.; Parmeggiani, C.; Faggi, E.; Bonaccini, C.; Gratteri, P.;
Sim, L.; Gloster, T. M.; Roberts, S.; Davies, G. J.; Rose, D. R.; Goti,
A. Chem.sEur. J. 2009, 15, 1627–1636.
45%): [R]22 -6.0 (c 0.25, CH2Cl2); IR (CDCl3) cm-1 3689, 3605,
D
2956, 2926, 2854, 1732, 161, 1457, 1378; 1H NMR (CDCl3) δ
7.35-7.18 (m, 20H, Ar), 4.62-4.44 (m, 8H, Bn), 4.29-4.26 (m, 1H,
H-6), 4.03 (pseudo t, J ) 4.9 Hz, 1H, H-2), 3.89 (t, J ) 4.2 Hz, 1H,
H-1), 3.83 (dd, J ) 6.9, 4.6 Hz, 1H, H-7), 3.62 (m, 1H, H-7a),
3.57-3.49 (m, 2H, H-8), 3.33-3.30 (m, 1H, Ha-5), 3.03-2.99 (m,
2H, H-3 + Hb-5); 13C NMR (CDCl3) δ 137.6-137.1 (s, 4C, Ar),
128.3-127.4 (d, 20C, Ar), 85.4 (d, 2C, C-1 + C-2), 82.5 (d, C-7),
73.0-71.3 (5C, 4Bn + C-8), 70.5 and 70.3 (d, 2C, C-6 + C-7a), 69.8
(d, C-3), 60.2 (t, C-5); MS (ESI) m/z 566 (100, [M + H]+); anal. C,
76.40%; H, 7.37%; N, 2.75%, calcd for C36H39NO5, C, 76.43%; H,
6.95%; N, 2.48%.
(1R,2R,3R,6S,7S,7aS)-3-(Hydroxymethyl)hexahydro-1H-pyrrolizin-
1,2,6,7-tetraol ((-)-uniflorine A, 3). HCl 37% (0.1 mL) and 10% Pd
on C (33 mg) were added to a solution of 12 (35 mg, 0.062 mmol) in
MeOH (4 mL). The suspension was stirred under H2 atmosphere for 4
days, then filtered through Celite and washed with MeOH. Evaporation
of the solvent under reduced pressure afforded crude 3, which was
transferred to a column of Dowex 50WX8 and washed with MeOH
(10 mL) and H2O (10 mL) to remove nonbasic impurities, then with
6% NH4OH (15 mL) to elute (-)-uniflorine A (3) as a yellowish solid
(10) Brandi, A.; Cardona, F.; Cicchi, S.; Cordero, F. M.; Goti, A.
Chem.sEur. J. 2009, 15, 7808–7821.
(11) Ritthiwigrom, T.; Pyne, S. G. Org. Lett. 2008, 10, 2769–2771.
(12) For other syntheses of casuarine, see: (a) Denmark, S. E.; Hurd, A. R.
Org. Lett. 1999, 1, 1311–1314. (b) Denmark, S. E.; Hurd, A. R. J.
Org. Chem. 2000, 65, 2875–2886. (c) Izquierdo, I.; Plaza, M. T.;
Tamayo, J. A. Tetrhedron 2005, 61, 6527–6533. (d) Van Ameijde, J.;
Horne, G.; Wormald, M. R.; Dwek, R. A.; Nash, R. J.; Jones, P. W.;
Evinson, E. L.; Fleet, G. W. J. Tetrahedron: Asymmetry 2006, 17,
2702–2712. (e) Bell, A. A.; Pickering, L.; Watson, A. A.; Robert,
J. N.; Pan, Y. T.; Elbein, A. D.; Fleet, G. W. J. Tetrahedron Lett.
1997, 38, 5869–5872.
(13) Cardona, F.; Faggi, E.; Liguori, F.; Cacciarini, M.; Goti, A. Tetrahe-
dron Lett. 2003, 44, 2315–2318. (b) Carmona, A. T.; Wightman, R. H.;
Robina, I.; Vogel, P. HelV. Chim. Acta 2003, 86, 3066–3073. (c)
Desvergnes, S.; Py, S.; Valle´e, Y. J. Org. Chem. 2005, 70, 1459–
1462. (d) Revuelta, J.; Cicchi, S.; Goti, A.; Brandi, A. Synthesis 2007,
4, 485–504. (e) Cicchi, S.; Marradi, M.; Vogel, P.; Goti, A. J. Org.
Chem. 2006, 71, 1614–1619. (f) Tsou, E.-L.; Yeh, Y.-T.; Liang, P.-
H.; Cheng, W.-C. Tetrahedron 2009, 65, 93–100.
(9 mg, 0.044 mmol, 71%): mp 177-180 °C; [R]21 -6.9 (c 0.415,
D
1
H2O); H NMR (D2O) δ 4.23 (q, J ) 5.2 Hz, 1H, H-6), 4.08 (pseudo
t, J ) 4.7 Hz, 1H, H-7), 3.83 (t, J ) 7.4 Hz, 1H, H-1), 3.71 (dd, J )
8.8, 7.6 Hz, 1H, H-2), 3.65 (dd, J ) 11.9, 3.7 Hz, 1H, Ha-8), 3.50 (dd,
J ) 11.9, 6.4 Hz, 1H, Hb-8), 3.08 (dd, J ) 7.2, 5.0 Hz, 1H, H-7a),
2.97 (dd, J ) 12.1, 5.4 Hz, 1H, Ha-5), 2.89 (dd, J ) 12.1, 5.0 Hz, 1H,
Hb-5), 2.70 (ddd, J ) 9.1, 6.4, 3.7 Hz, 1H, H-3); 13C NMR (D2O) δ
78.7 (d, C-1), 77.5 (d, C-2), 75.7 (d, C-7), 72.0 (d, C-6), 71.8 (d, C-7a),
70.9 (d, C-3), 62.3 (t, C-8), 58.1 (t, C-5); MS (ESI) m/z 206 (100, [M
+ H]+), 158 (10), 132 (13), 118 (22), 95 (30), 79 (73), 55 (17); anal.
C, 46.85%; H, 7.68%; N, 7.11%, calcd for C8H15NO5, C, 46.82%; H,
7.37%; N, 6.83%.
NP900435D